An acneiform eruption due to erlotinib: prognostic implications and management.
Journagan
Susan
S
Obadiah
Joseph
J
D017486:Acneiform Eruptions / Q000139:chemically induced*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D000069347:Erlotinib Hydrochloride; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D011379:Prognosis; D011799:Quinazolines / Q000009:adverse effects*
D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; D066246:ErbB Receptors